$item.Name

首页>试剂标物>常用实验试剂>普通试剂

Mouse/Rat FGF-23 ELISA Kit

型号
北京科瑞美科技有限公司

免费会员 

代理商

该企业相似产品

25羟基维生素D测试剂盒

在线询价

大鼠甲状旁腺激素C端肽ELISA试剂盒

在线询价

25羟基维生素D试剂盒 液相色谱法代测服务

在线询价

25羟基维生素D试剂盒

在线询价
eBioscience公司产品,德国欧蒙诊断试剂盒,妇科检测试剂盒,美国Raybiotech公司产品,Invitrogen公司产品Millipore公司产品BD公司产品,Santa

  北京科瑞美科技有限公司是一家专门从事临床实验室诊断产品销售及售后服务的企业。经过几年的不懈努力,得到广大用户的肯定与支持。


  科瑞美公司以引进“新产品、新技术”为己任,目前已拥有四十多家国外品牌,产品涉及重组蛋白、抗体、细胞因子、骨代谢、传染病、肿瘤、激素、心肌标志物、糖尿病、自身免疫、蛋白质芯片、优生优育等众多领域。相当多的产品和相关技术在国内的推广与国外几乎是同步的,为广大的科研工作者提供了有力的支持。


  多年来我们不断推陈出新,积极倡导“锐意进取、精益求精、信守承诺、探索求新”的企业精神,以“保证质量,提高客户满意度”为经营宗旨,以质量求生存,以品种求发展,以科学技术为先导,致力于中国检验领域的缜密科学。面对未来,我们将一如既往的提供高质量的产品、优惠的价格及优质的服务。并秉持“专业、真诚”的服务宗旨,期待着与您在更为广阔的天地里,成就共同发展,共创双赢的目标!期待着与您的合作!


  我们坚信,只有不断创新,不断进步,我们才有更强大的生命力!


详细信息

一.产品名称:

通用名称:大/小鼠成纤维细胞生长因子23 ELISA试剂盒

英文名称:Mouse/Rat FGF-23 ELISA Kit

二.Mouse FGF-23 ELISA介绍:

Mouse/Rat FGF-23 ELISA Kit is intended for research use only in the quantitative determination of Mouse FGF-23 levels in serum, plasma or cell culture media. This assay is also useful in the determination of Rat FGF-23 levels.
 

Fibroblast growth factor 23 (FGF-23) is a recently discovered, novel member of a large family of related proteins. Its gene encodes a 251 amino acid protein. The amino-terminal portion of FGF-23 (aa 1-24) is hydrophobic and is likely to serve as a signal peptide allowing its secretion into the blood circulation. Its carboxyl-terminal portion (aa 180-251) shares only limited amino acid homology with other members of the FGF family of proteins.


Renal phosphate wasting disorders leading to hypophosphatemia are among the causes of defective mineralization of bone and growth plate development. Autosomal dominant hypophosphatemic rickets (ADHR), a rare genetic disorder, results from one of several different FGF-23 mutations that make the protein resistant to proteolytic cleavage. Furthermore, tumors that cause oncogenic osteomalacia (OOM) have been shown to overexpress FGF-23 mRNA making it likely that elevated concentrations of FGF-23 in the blood are the cause of renal phosphate wasting. Consistent with this conclusion, the administration of recombinant FGF-23 to rodents was shown to increase urinary excretion of phosphate thus leading to hypophosphatemia and osteomalacia/rickets. Recent studies with chronic kidney disease (CKD) patients have shown FGF-23 to be an early predictor of abnormal renal tubular function, bone mineralization, disease progression and over-all mortality risk.


Taken together, all currently available data suggest that the measurement of FGF-23 levels may provide an important diagnostic tool for the evaluation of hypophosphatemic and hyperphosphatemic disorders.
 

如需了解更多产品,请北京科瑞美公司。

 

相关技术文章

同类产品推荐

相关分类导航

产品参数

企业未开通此功能
详询客服 : 0571-87858618
提示

请选择您要拨打的电话:

当前客户在线交流已关闭
请电话联系他 :